Taken together, these data supported a presumed role for SORCS2 in mitigating noxious insults imposed on astrocytes by Aβ, and they suggested SORCS2 deficiency as a useful experimental paradigm to investigate consequences of heightened astrocyte distress in AD. The gene discussed is SORCS2; the disease is Alzheimer disease.